基于人工智能的预测模型在5个外部弥漫性大B细胞淋巴瘤PET/CT数据集中的验证
本研究在5项独立临床试验中验证既往开发的深度学习模型,共纳入1132例弥漫性大B细胞淋巴瘤患者(296例训练、836例外部队列验证),主要结局为2年进展时间。深度学习模型AUC为0.66,显著高于国际预后指数(IPI)的0.60(P < 0.01);影像组学模型AUC更高,其中PET模型最高(AUC 0.71,P < 0.05),深度学习与临床PET模型性能相当(AUC 0.69,P > 0.05)。
要点
- 深度学习模型在全部外部试验中预测性能均高于IPI,且生存曲线分离更好。
- 深度学习模型AUC 0.66,显著高于IPI的AUC 0.60(P < 0.01)。
- PET模型AUC最高(0.71,P < 0.05),深度学习与临床PET模型相当(AUC 0.69,P > 0.05)。
核心结论
- 深度学习模型在所有试验中预测结局,性能高于IPI且生存曲线分离更好。
- 该模型无需肿瘤勾画即可预测弥漫性大B细胞淋巴瘤治疗结局,但代价是预后性能低于影像组学。
研究设计与样本
- 在5项独立临床试验中验证既往开发的深度学习模型。
- 共纳入1132例弥漫性大B细胞淋巴瘤患者,其中296例用于训练、836例用于外部验证。
- 主要结局为2年进展时间,模型基于PET/CT扫描的最大强度投影训练。
- 临床PET模型纳入代谢肿瘤体积、最大病灶到另一病灶的最大距离、SUVpeak、年龄和体能状态。
- PET模型纳入代谢肿瘤体积、最大病灶到另一病灶的最大距离和SUVpeak。
主要发现
- IPI在所有外部数据上AUC为0.60。
- 深度学习模型AUC为0.66,显著高于IPI(P < 0.01)。
- 在每个独立临床试验中,深度学习模型均持续优于IPI。
- 影像组学模型在所有临床试验中AUC均保持更高。
- 深度学习与临床PET模型性能相当(AUC 0.69,P > 0.05);PET模型AUC最高(0.71,P < 0.05)。
关键数值与推荐
- 深度学习模型外部验证AUC 0.66(P < 0.01 vs IPI的0.60)。
- 临床PET模型AUC 0.69,与深度学习模型相当(P > 0.05)。
- PET模型AUC 0.71(P < 0.05),为所有模型中最高。
- IPI在所有外部数据上AUC 0.60。
临床怎么用
- 原文未据此给出推荐。
局限性
- 深度学习模型无需肿瘤勾画即可预测治疗结局,但代价是预后性能低于影像组学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this study was to validate a previously developed deep learning model in 5 independent clinical trials. The predictive performance of this model was compared with the international prognostic index (IPI) and 2 models incorporating radiomic PET/CT features (clinical PET and PET models). Methods: In total, 1,132 diffuse large B-cell lymphoma patients were included: 296 for training and 836 for external validation. The primary outcome was 2-y time to progression. The deep learning model was trained on maximum-intensity projections from PET/CT scans. The clinical PET model included metabolic tumor volume, maximum distance from the bulkiest lesion to another lesion, SUVpeak, age, and performance status. The PET model included metabolic tumor volume, maximum distance from the bulkiest lesion to another lesion, and SUVpeak Model performance was assessed using the area under the curve (AUC) and Kaplan-Meier curves. Results: The IPI yielded an AUC of 0.60 on all external data. The deep learning model yielded a significantly higher AUC of 0.66 (P < 0.01). For each individual clinical trial, the model was consistently better than IPI. Radiomic model AUCs remained higher for all clinical trials. The deep learning and clinical PET models showed equivalent performance (AUC, 0.69; P > 0.05). The PET model yielded the highest AUC of all models (AUC, 0.71; P < 0.05). Conclusion: The deep learning model predicted outcome in all trials with a higher performance than IPI and better survival curve separation. This model can predict treatment outcome in diffuse large B-cell lymphoma without tumor delineation but at the cost of a lower prognostic performance than with radiomics.
引用
- Ferrández MC, Golla SSV, Eertink JJ, et al. Validation of an Artificial Intelligence-Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma. J Nucl Med. 2024. PMID: 39362767. doi:10.2967/jnumed.124.268191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。